Baker Tilly has launched rwdNOW self-service market assessment tool aimed at “helping life sciences companies pinpoint niche markets with high opportunity levels for the adoption of their products”.
The tool will leverage medicare and commercial insurance claims data to provide life sciences companies with insight into payer reimbursement trends and patient resource consumption over time, layered with therapeutic or medical condition details, provider specialty, and patient and referral characteristics.
David Gregory, Baker Tilly healthcare consulting industry leader, said: “With rising competition in the U.S. market, it is critical for life sciences companies to create a data-driven market access strategy that supports product adoption and coverage at all levels.
“Life science organizations need to appropriately develop and integrate a market access strategy that accounts for both current and future market needs and trends to avoid significant hurdles and generate a successful product launch, return on investment and long-term profitability.”
He added: “We understand the challenges companies face when identifying attainable markets in which to deploy internal resources to grow market adoption.
“Baker Tilly’s rwdNOW tool enables companies to better understand the market and identify potential changes to achieve their market access goals.”